Cargando…
Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
BACKGROUND: Bronchoalveolar lavage (BAL) is one of the fundamental examinations for the differential diagnosis of interstitial lung diseases (ILDs), and lymphocytosis strongly indicates alternative diagnoses rather than idiopathic pulmonary fibrosis. However, the BALF lymphocytosis is observed in se...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254956/ https://www.ncbi.nlm.nih.gov/pubmed/34217348 http://dx.doi.org/10.1186/s13023-021-01926-x |
_version_ | 1783717809636769792 |
---|---|
author | Horimasu, Yasushi Yamaguchi, Kakuhiro Sakamoto, Shinjiro Masuda, Takeshi Miyamoto, Shintaro Nakashima, Taku Iwamoto, Hiroshi Fujitaka, Kazunori Hamada, Hironobu Hattori, Noboru |
author_facet | Horimasu, Yasushi Yamaguchi, Kakuhiro Sakamoto, Shinjiro Masuda, Takeshi Miyamoto, Shintaro Nakashima, Taku Iwamoto, Hiroshi Fujitaka, Kazunori Hamada, Hironobu Hattori, Noboru |
author_sort | Horimasu, Yasushi |
collection | PubMed |
description | BACKGROUND: Bronchoalveolar lavage (BAL) is one of the fundamental examinations for the differential diagnosis of interstitial lung diseases (ILDs), and lymphocytosis strongly indicates alternative diagnoses rather than idiopathic pulmonary fibrosis. However, the BALF lymphocytosis is observed in several ILDs. We considered that quantitative evaluation of the BALF lymphocyte nuclear morphology would be useful in the differential diagnosis of ILDs with increased BALF lymphocyte fraction. RESULTS: One hundred and twenty-one patients with ILDs having increased BALF lymphocyte fraction were recruited (68 in the development cohort and 53 in the validation cohort). In the development cohort, BALF lymphocyte nuclei in sarcoidosis patients showed significantly smaller areas, shorter perimeters, lower radius ratios, and increased roundness than those of other ILD patients (p < 0.001 for each). Next, the fractions of lymphocytes with small areas, short perimeters, low radius ratios, and increased roundness, which were determined based on receiver operating characteristic (ROC) analyses-based thresholds, were demonstrated to be higher in sarcoidosis patients than in the other ILD patients (p < 0.001 for each). Furthermore, when we combined size-representing parameters with shape-representing parameters, the fraction of lymphocytes with small and round nuclei showed approximately 0.90 of area under the ROC curve in discriminating sarcoidosis both in the development cohort and the validation cohort. CONCLUSION: This study is the first to demonstrate the usefulness of quantitative parameters of BALF lymphocyte nuclear morphology as novel biomarkers for sarcoidosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01926-x. |
format | Online Article Text |
id | pubmed-8254956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82549562021-07-06 Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis Horimasu, Yasushi Yamaguchi, Kakuhiro Sakamoto, Shinjiro Masuda, Takeshi Miyamoto, Shintaro Nakashima, Taku Iwamoto, Hiroshi Fujitaka, Kazunori Hamada, Hironobu Hattori, Noboru Orphanet J Rare Dis Research BACKGROUND: Bronchoalveolar lavage (BAL) is one of the fundamental examinations for the differential diagnosis of interstitial lung diseases (ILDs), and lymphocytosis strongly indicates alternative diagnoses rather than idiopathic pulmonary fibrosis. However, the BALF lymphocytosis is observed in several ILDs. We considered that quantitative evaluation of the BALF lymphocyte nuclear morphology would be useful in the differential diagnosis of ILDs with increased BALF lymphocyte fraction. RESULTS: One hundred and twenty-one patients with ILDs having increased BALF lymphocyte fraction were recruited (68 in the development cohort and 53 in the validation cohort). In the development cohort, BALF lymphocyte nuclei in sarcoidosis patients showed significantly smaller areas, shorter perimeters, lower radius ratios, and increased roundness than those of other ILD patients (p < 0.001 for each). Next, the fractions of lymphocytes with small areas, short perimeters, low radius ratios, and increased roundness, which were determined based on receiver operating characteristic (ROC) analyses-based thresholds, were demonstrated to be higher in sarcoidosis patients than in the other ILD patients (p < 0.001 for each). Furthermore, when we combined size-representing parameters with shape-representing parameters, the fraction of lymphocytes with small and round nuclei showed approximately 0.90 of area under the ROC curve in discriminating sarcoidosis both in the development cohort and the validation cohort. CONCLUSION: This study is the first to demonstrate the usefulness of quantitative parameters of BALF lymphocyte nuclear morphology as novel biomarkers for sarcoidosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01926-x. BioMed Central 2021-07-03 /pmc/articles/PMC8254956/ /pubmed/34217348 http://dx.doi.org/10.1186/s13023-021-01926-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Horimasu, Yasushi Yamaguchi, Kakuhiro Sakamoto, Shinjiro Masuda, Takeshi Miyamoto, Shintaro Nakashima, Taku Iwamoto, Hiroshi Fujitaka, Kazunori Hamada, Hironobu Hattori, Noboru Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
title | Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
title_full | Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
title_fullStr | Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
title_full_unstemmed | Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
title_short | Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
title_sort | quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254956/ https://www.ncbi.nlm.nih.gov/pubmed/34217348 http://dx.doi.org/10.1186/s13023-021-01926-x |
work_keys_str_mv | AT horimasuyasushi quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT yamaguchikakuhiro quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT sakamotoshinjiro quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT masudatakeshi quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT miyamotoshintaro quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT nakashimataku quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT iwamotohiroshi quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT fujitakakazunori quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT hamadahironobu quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis AT hattorinoboru quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis |